Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy.
Davern M, Donlon NE, Sheppard AS, Majcher KD, Connell FO, Heeran AB, Grant M, Farrell RA, Hayes C, Bracken-Clarke D, Conroy MJ, Foley E, Toole DO, Bhardwaj A, Ravi N, Reynolds JV, Maher SG, Sullivan JO, Lysaght J. Davern M, et al. Among authors: foley e. J Cancer Res Clin Oncol. 2023 Jul;149(7):3753-3774. doi: 10.1007/s00432-022-04283-9. Epub 2022 Aug 20. J Cancer Res Clin Oncol. 2023. PMID: 35986757 Free PMC article.
Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma.
Melo AM, O'Brien AM, Phelan JJ, Kennedy SA, Wood NAW, Veerapen N, Besra GS, Clarke NE, Foley EK, Ravi A, MacCarthy F, O'Toole D, Ravi N, Reynolds JV, Conroy MJ, Hogan AE, O'Sullivan J, Dunne MR. Melo AM, et al. Among authors: foley ek. Front Immunol. 2019 Jul 10;10:1580. doi: 10.3389/fimmu.2019.01580. eCollection 2019. Front Immunol. 2019. PMID: 31354725 Free PMC article.
CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies.
Melo AM, Conroy MJ, Foley EK, Dockry É, Breen EP, Reynolds JV, Lysaght J, Doherty DG. Melo AM, et al. Among authors: foley ek. Cancer Immunol Immunother. 2020 Jun;69(6):969-982. doi: 10.1007/s00262-020-02514-x. Epub 2020 Feb 20. Cancer Immunol Immunother. 2020. PMID: 32078695 Free PMC article.
Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib.
Buckley AM, Dunne MR, Morrissey ME, Kennedy SA, Nolan A, Davern M, Foley EK, Clarke N, Lysaght J, Ravi N, O'Toole D, MacCarthy F, Reynolds JV, Kennedy BN, O'Sullivan J. Buckley AM, et al. Among authors: foley ek. Sci Rep. 2020 Jul 21;10(1):12105. doi: 10.1038/s41598-020-68777-7. Sci Rep. 2020. PMID: 32694701 Free PMC article.
Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma-An Emerging Role for Chemokines.
Donlon NE, Sheppard A, Davern M, O'Connell F, Phelan JJ, Power R, Nugent T, Dinneen K, Aird J, Greene J, Nevins Selvadurai P, Bhardwaj A, Foley EK, Ravi N, Donohoe CL, Reynolds JV, Lysaght J, O'Sullivan J, Dunne MR. Donlon NE, et al. Among authors: foley ek. Cancers (Basel). 2020 Nov 13;12(11):3356. doi: 10.3390/cancers12113356. Cancers (Basel). 2020. PMID: 33202734 Free PMC article.
Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells.
Davern M, Donlon NE, Sheppard A, Connell FO, Hayes C, Bhardwaj A, Foley E, Toole DO, Lynam-Lennon N, Ravi N, Reynolds JV, Maher SG, Lysaght J. Davern M, et al. Among authors: foley e. Transl Oncol. 2021 Jun;14(6):101062. doi: 10.1016/j.tranon.2021.101062. Epub 2021 Mar 22. Transl Oncol. 2021. PMID: 33765543 Free PMC article.
496 results